Plant Summary
Plant Information
TCMBank_ID: | TCMBANKHE005671 |
YEM_ID: | YEM-254 |
ID: | TCMBANKHE005671/YEM-254 |
植物拉丁名: |
|
功能与主治: | To expel phlegm and relieve malaria/Malaria, scrofula. |
药用植物名: | 常山 |
药名: | 常山 |
来源: | 云南民族药物志：第二卷 |
药用部位: | root |
使用民族: | 阿昌族/傣族/德昂族/哈尼族/基诺族/景颇族/拉祜族/苗族/佤族/瑶族/彝族 |
药味: | Cold; Pungent; Bitter |
经络: | Lung; Liver; Heart |
毒性: | Extremely Toxic |
临床特征: | Alpha, beta and gama-Dirchroine are three active components. 1. All of them are antimalarial agents. Gama-Dichroine being the most effecitve. 2. Beta-Dichroine is also an amebicide which is stronger than emetine. 3. Alpha and beta-Dichroine can reduce vac |
治疗类型: | 涌吐药 |
TCM_ID_id: | 7342 |
SymMap_id: | 60 |
TCMSP_id: | 84 |
植物对应的化合物
| 化合物ID | 化合物名 | 别名 | 分子式 | 分子质量 | Smiles |
|---|
| TCMBANKIN000399 | (E)-Pent-2-en-1-ol | pent-2-en-1-ol; trans-2-Penten-1-ol; 1576-96-1; 2-PENTEN-1-OL; 424447_ALDRICH; EINECS 216-416-2; 2-Penten-1-ol, (E)-; (2E)-2-Penten-1-ol; ZINC06661425; 20273-24-9 | C5H10O | 86.13 | CCC=CCO |
| TCMBANKIN000842 | 1-Methyl-5,6-divinyl-1-cyclohexene | C11H16 | 148.24 g/mol | CC1=CCCC(C1C=C)C=C | |
| TCMBANKIN001156 | l-tyrosine | CTK8H2070; TYROSIN HYDROCHLORIDE; AKOS005216971; L- Tyrosine; SCHEMBL246904 | C9H12ClNO3 | 217.65 g/mol | C1=CC(=CC=C1CC(C(=O)O)N)O.Cl |
| TCMBANKIN001416 | alpha-dirchroine | ||||
| TCMBANKIN001660 | 3-[3-[(2R,3S)-3-hydroxy-2-piperidyl]-2-oxo-propyl]quinazolin-4-one | 3-[3-[(2R,3S)-3-hydroxypiperidin-2-yl]-2-oxo-propyl]quinazolin-4-one; 3-[3-[(2R,3S)-3-hydroxy-2-piperidyl]-2-keto-propyl]quinazolin-4-one; 3-[3-[(2R,3S)-3-hydroxypiperidin-2-yl]-2-oxopropyl]quinazolin-4-one; 3-[3-[(2R,3S)-3-hydroxy-2-piperidinyl]-2-oxopropyl]-4-quinazolinone | 301.38 | ||
| TCMBANKIN001917 | Hexadienal | (2E,4E)-hexa-2,4-dienal; FEMA No. 3429; AIDS-017580; trans,trans-2,4-Hexadienal; 73506-81-7; Hexa-2,4-dienal; BRN 1698401; AIDS017580; NSC 16184; 4488-48-6; 1,3-Pentadiene-1-carboxaldehyde; 2,4-Hexadienal, (E,E)-; 2,4-Hexadienal, (2E,4E)-; NSC 68096; 52477_FLUKA; EINECS 205-564-3; CCRIS 5124; 2,4-Hexadienal, trans,trans-; SBB006613; HSDB 7239; AI3-31142; W342904_ALDRICH; 2,4-Hexadienal (89% trans,trans;11% cis,trans); NCGC00090786-01; 142-83-6; 2-Propyleneacrolein; ZINC01733897; LMFA06000006; CCRIS 4030; InChI=1/C6H8O/c1-2-3-4-5-6-7/h2-6H,1H3/b3-2+,5-4; 3-Propyleneacrolein; 4-01-00-03545 (Beilstein Handbook Reference); 2,4-Hexadienal (89% trans,trans-, 11% cis,trans-); 180343_ALDRICH; Sorbic aldehyde | C6H8O | 96.13 g/mol | CC=CC=CC=O |
| TCMBANKIN003134 | Pteleprenine | 6-methoxy-9-methyl-7-(3-methylbut-2-enyl)-[1,3]dioxolo[4,5-h]quinolin-8-one; 17232-50-7 | C17H19NO4 | 301.34 | CC(=CCC1=C(C2=C(C3=C(C=C2)OCO3)N(C1=O)C)OC)C |
| TCMBANKIN003289 | Isobutyryl chloride | Isobutyryl chloride [UN2395] [Flammable liquid]; 79-30-1; UN2395; 2-Methylpropionyl chloride; EINECS 201-194-1; 139122_ALDRICH; Chloro isopropyl ketone; 58420_FLUKA; 120126-85-4; Isobutyroyl chloride; Isobutyric acid chloride; 2-Methylpropanoyl chloride; Isobutanoyl chloride; ZINC01850092; alpha-Methylpropionyl chloride; Dimethylacetyl chloride; PROPANOYL CHLORIDE, 2-METHYL-; InChI=1/C4H7ClO/c1-3(2)4(5)6/h3H,1-2H | C4H7ClO | 106.55 | CC(C)C(=O)Cl |
| TCMBANKIN003902 | 4,8-dimethoxy-1-methyl-3-(3-methyl-2-oxobutyl)quinolin-2-one | 3-(2-keto-3-methyl-butyl)-4,8-dimethoxy-1-methyl-carbostyril; 4,8-dimethoxy-1-methyl-3-(3-methyl-2-oxo-butyl)quinolin-2-one; 4,8-dimethoxy-1-methyl-3-(3-methyl-2-oxobutyl)-2-quinolinone | 303.39 | ||
| TCMBANKIN004925 | Vinyl methacrylate | 434620_ALDRICH; 4245-37-8; Methacrylic acid, vinyl ester; ZINC01665002; 2-Propenoic acid, 2-methyl-, ethenyl ester; NSC 32618; vinyl 2-methylprop-2-enoate; 2-methylprop-2-enoic acid vinyl ester; 2-methylacrylic acid vinyl ester; Methacrylic acid, vinyl ester (8CI); NSC32618; 2-Methyl-2-propenoic acid, ethenyl ester; EINECS 224-205-1; ethenyl 2-methylprop-2-enoate | C6H8O2 | 112.13 | CC(=C)C(=O)OC=C |
| TCMBANKIN006118 | NEOPENTANE | 1,1,1-Trimethylethane; 2,2-Dimethylpropane [UN2044] [Flammable gas]; 463-82-1; BRN 1730722; EINECS 207-343-7; Tetramethylmethane; 2,2-Dimethylpropane; UN2044; tert-Pentane; HSDB 110; Propane, 2,2-dimethyl-; 4-01-00-00333 (Beilstein Handbook Reference); (CH3)4C; CHEBI:30358 | C5H12 | 72.15 | CC(C)(C)C |
| TCMBANKIN007587 | 4,8-dimethoxy-1-methyl-3-(3-methyl-2-oxobut-3-enyl)quinolin-2-one | 4,8-dimethoxy-1-methyl-3-(3-methyl-2-oxo-but-3-enyl)quinolin-2-one; 3-(2-keto-3-methyl-but-3-enyl)-4,8-dimethoxy-1-methyl-carbostyril; 4,8-dimethoxy-1-methyl-3-(3-methyl-2-oxobut-3-enyl)-2-quinolinone | 301.37 | ||
| TCMBANKIN007637 | (1S,5S)-1-isopropyl-4-methylenebicyclo[3.1.0]hexane | (1S,5S)-1-isopropyl-4-methylene-bicyclo[3.1.0]hexane; (1S,5S)-4-methylidene-1-propan-2-ylbicyclo[3.1.0]hexane; (1S,5S)-4-methylidene-1-propan-2-yl-bicyclo[3.1.0]hexane | C10H16 | 136.23 g/mol | CC(C)C12CCC(=C)C1C2 |
| TCMBANKIN007791 | 2-Propylfuran | Furan, 2-propyl-; EINECS 224-182-8; AI3-26552; 4229-91-8; NSC35553; ZINC01668229 | C7H10O | 110.15 | CCCC1=CC=CO1 |
| TCMBANKIN011719 | songorine | Napellonine; Zongorine; 509-24-0; STOCK1N-51040; C08707; MolPort-002-525-082; AKOS030502518; (1R,2R,5S,7R,8R,9R,13R,16S,17R)-11-ETHYL-7,16-DIHYDROXY-13-METHYL-6-METHYLIDENE-11-AZAHEXACYCLO[7.7.2.1?,?.0(1),(1)?.0(2),?.0(1)(3),(1)?]NONADECAN-4-ONE; BG01646908; Songorine; CHEBI:9196 | C22H31NO3 | 357.49 | CCN1CC2(CCC(C34C2CC(C31)C56C4CC(=O)C(C5)C(=C)C6O)O)C |
| TCMBANKIN012499 | 3-methyl-3,4-divinyl-1-cyclohexene | C11H16 | 148.24 g/mol | CC1(C=CCCC1C=C)C=C | |
| TCMBANKIN012899 | (2R)-1-(4,8-dimethoxyfuro[2,3-b]quinolin-7-yl)oxy-3-methylbutane-2,3-diol | (2R)-1-(4,8-dimethoxyfuro[2,3-b]quinolin-7-yl)oxy-3-methyl-butane-2,3-diol; Prestwick3_000665; STOCK1N-02929; BSPBio_000729; (2R)-1-[(4,8-dimethoxy-7-furo[2,3-b]quinolinyl)oxy]-3-methylbutane-2,3-diol; ZINC00035526; BPBio1_000803 | C18H21NO6 | 347.4 g/mol | CC(C)(C(COC1=C(C2=C(C=C1)C(=C3C=COC3=N2)OC)OC)O)O |
| TCMBANKIN013110 | 4''-hydroxyimperatorin 4''-o-β-d-glucopyra-noside | C22H24O10 | CC(=CCOC1=C2C(=CC3=C1OC=C3)C=CC(=O)O2)COC4C(C(C(C(O4)CO)O)O)O | ||
| TCMBANKIN013263 | megastigma-3,7(E),9-triene | C13H20 | 176.3 g/mol | CC1C=CCC(C1C=CC=C)(C)C | |
| TCMBANKIN015265 | sarmentosin | 4CN-1777; 2-Butenenitrile, 4-(beta-D-glucopyranosyloxy)-2-(hydroxymethyl)-, (E)-; (Z)-2-(hydroxymethyl)-4-[(2R,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxybut-2-enenitrile; AC1O5Q6P; AKOS032948571; Sarmentosine | C11H17NO7 | 275.25 g/mol | C(C=C(CO)C#N)OC1C(C(C(C(O1)CO)O)O)O |
| TCMBANKIN015667 | cyclosativene | (+)-cyclosativene; Cyclosativene; (+)-cycloisosativene; cycloiso sativene | C15H24 | 204.35 | CC(C)C1CCC2(C3C1C4C2(C4C3)C)C |
| TCMBANKIN017270 | (2e,6 e,10 e,14z)-17,20-dihydroxygeranylnerol | C20H34O3 | CC(=CCCC(=CCO)CO)CCC=C(C)CCC=C(C)CO | ||
| TCMBANKIN018398 | l-aspartic acid | KB-259355; LT03328317; L-Aspartic acid, potassium salt (1:1); potassium 3-azanyl-4-oxidanyl-4-oxidanylidene-butanoate; AKOS016010461; RL05814; kaliumhydrogenaspartat; DL-Aspartic acid potassium salt; l-asparticacid; EINECS 213-088-2; J-002598; Potassium hydrogen DL-aspartate; AX8148812; BG00906804; Potassium 3-amino-3-carboxypropanoate; L-Aspartic acid, potassium salt (1:?); AK117181; 923-09-1; potassium 3-amino-4-hydroxy-4-oxobutanoate; X5496; A844192; L-Aspartic acid, potassium salt; FT-0625443; C4H6KNO4 | C4H6KNO4 | 171.19 g/mol | C(C(C(=O)O)N)C(=O)[O-].[K+] |
| TCMBANKIN018615 | 3-[(3R,9S,9aR)-9-hydroxy-2-keto-quinolizidin-3-yl]quinazolin-4-one | 3-[(3R,9S,9aR)-9-hydroxy-2-oxo-1,3,4,6,7,8,9,9a-octahydroquinolizin-3-yl]-4-quinazolinone; 3-[(3R,9S,9aR)-9-hydroxy-2-oxo-1,3,4,6,7,8,9,9a-octahydroquinolizin-3-yl]quinazolin-4-one | 313.39 | ||
| TCMBANKIN018721 | 3-[(2R)-2,3-dihydroxy-3-methyl-butyl]-4-methoxy-1-methyl-carbostyril | 3-[(2R)-2,3-dihydroxy-3-methylbutyl]-4-methoxy-1-methylquinolin-2-one; 3-[(2R)-2,3-dihydroxy-3-methyl-butyl]-4-methoxy-1-methyl-quinolin-2-one; 2(1H)-Quinolinone, 3-(2,3-dihydroxy-3-methylbutyl)-4-methoxy-1-methyl-, (R)-; 27495-36-9; 3-[(2R)-2,3-dihydroxy-3-methylbutyl]-4-methoxy-1-methyl-2-quinolinone | C16H21NO4 | 291.34 | CC(C)(C(CC1=C(C2=CC=CC=C2N(C1=O)C)OC)O)O |
| TCMBANKIN018873 | Orixinone | 1-(6,8-dimethoxy-[1,3]dioxolo[4,5-h]quinolin-7-yl)-3-methylbutan-2-one; 1-(6,8-dimethoxy-[1,3]dioxolo[4,5-h]quinolin-7-yl)-3-methyl-butan-2-one; orixinone | C17H19NO5 | 317.34 g/mol | CC(C)C(=O)CC1=C(C2=C(C3=C(C=C2)OCO3)N=C1OC)OC |
| TCMBANKIN020610 | 3-hexenyl acetate butyrate | ||||
| TCMBANKIN022737 | 1,1-diethylpropylbenzene | (1,1-DIETHYLPROPYL)BENZENE; 4170-84-7; Benzene, (1,1-diethylpropyl)-; 4170-07-4; 3-ethylpentan-3-ylbenzene | C13H20 | 176.3 g/mol | CCC(CC)(CC)C1=CC=CC=C1 |
| TCMBANKIN023075 | aconitan a, b, c, d | ||||
| TCMBANKIN024304 | Kokusagine | kokusagine | C13H9NO4 | 243.21 g/mol | COC1=C2C=COC2=NC3=C1C=CC4=C3OCO4 |
| TCMBANKIN025795 | daucosterol_qt | Daucosterol_qt | C35H60O6 | 576.85 | |
| TCMBANKIN026150 | gama-dirchroine | ||||
| TCMBANKIN026901 | beta-dirchroine | AJ-54457; (E)-3-(3-(3-Hydroxy-2-piperidinyl)acetonyl)-4-(3H)-quinazolinone; Febrifugine;; 3-(3-(3-Hydroxy-2-piperidinyl)-2-oxopropyl)-4(3H)-quinazolinone; (E)-3-(3-(3-Hydroxy-2-piperidinyl)-2-oxopropyl)-4(3H)-quinazolinone; 4(3H)-Quinazolinone, 3-(3-(3-hydroxy-2-piperidinyl)-2-oxopropyl)-, (2S-trans)-; UNII-89UWD0FH2I; Dichroin; ZINC5641945; Febrifugine (8CI); 24159-07-7; trans-3-(beta-Keto-gamma-(3-hydroxy-2-piperidyl)propyl)-4-quinazolone; SCHEMBL9542831; Febrifugine; 3-[3-[3(S)-Hydroxypiperidin-2(R)-yl]-2-oxopropyl]-3,4-dihydroquinazolin-4-one; BC650542; 89UWD0FH2I | C16H19N3O3 | 301.34 g/mol | C1CC(C(NC1)CC(=O)CN2C=NC3=CC=CC=C3C2=O)O |
| TCMBANKIN027201 | l-valine | L-valine zwitterion; ZB014973; AC1ODZ1H; (2S)-2-azaniumyl-3-methylbutanoate; val; CHEBI:57762; A837443; L-Val; L-2-Amino-3-methylbutyric acid; (S)-(+)-valine; (2S)-2-ammonio-3-methylbutanoate; (2S)-2-azaniumyl-3-methyl-butanoate; L-(+)-valine; CJ-04453 | C5H11NO2 | 117.15 g/mol | CC(C)C(C(=O)[O-])[NH3+] |
| TCMBANKIN028937 | (3a)-3-hydroxy-Urs-12-en-28-oic acid, methyl ester | C31H50O3 | 470.73 | ||
| TCMBANKIN029581 | 2,4,6-trimethyl-1-nonene | C12H24 | 168.32 g/mol | CCCC(C)CC(C)CC(=C)C | |
| TCMBANKIN029775 | 3-(2-keto-3-methyl-but-3-enyl)-4,8-dimethoxy-carbostyril | 4,8-dimethoxy-3-(3-methyl-2-oxo-but-3-enyl)-1H-quinolin-2-one; 4,8-dimethoxy-3-(3-methyl-2-oxobut-3-enyl)-1H-quinolin-2-one | 287.34 | ||
| TCMBANKIN030279 | (3R,4S)-3,4-dihydroxy-2,2,6-trimethyl-3,4-dihydropyrano[5,6-c]quinolin-5-one | 275.33 | |||
| TCMBANKIN030683 | talatisamine | C24H39NO5 | 421.57 | CCN1CC2(CCC(C34C2CC(C31)C5(CC(C6CC4C5C6O)OC)O)OC)COC | |
| TCMBANKIN031172 | CIS-3-heptenyl acetate | C9H16O2 | 156.22 | CCCC=CCCOC(=O)C | |
| TCMBANKIN031622 | (E)-hept-4-en-2-one | 24332-22-7; 4-Hepten-2-one, (E)-; (4E)-4-Hepten-2-one | C7H12O | 112.17 | CCC=CCC(=O)C |
| TCMBANKIN032730 | carmichaeline | Karakoline; 39089-30-0; Karacoline; 20-ethyl-16beta-methoxy-4-methylaconitane-1alpha,8,14alpha-triol; Carmicheline; C08693; STOCK1N-08515; Carmichaeline; CHEBI:6113; Aconitane-1,8,14-triol, 20-ethyl-16-methoxy-4-methyl-, (1-alpha,14-alpha,16-beta)- | C22H35NO4 | 377.5 g/mol | CCN1CC2(CCC(C34C2CC(C31)C5(CC(C6CC4C5C6O)OC)O)O)C |
| TCMBANKIN032804 | (2R)-2-methylpentanal | ZINC01681318; (2R)-2-methylvaleraldehyde | 100.18 | ||
| TCMBANKIN034090 | 2-[(1S,3Z,7Z)-4,8-dimethyl-1-cyclodeca-3,7-dienyl]propan-2-ol | 222.41 | |||
| TCMBANKIN035848 | (1R)-(-)-thuj-3-ene | C10H16 | 136.23 | ||
| TCMBANKIN035854 | Ethyl 3-butenoate | 3-Butenoic acid, ethyl ester; NSC44507; 1617-18-1; but-3-enoic acid ethyl ester; AI3-17636; ethyl but-3-enoate | C6H10O2 | 114.14 | CCOC(=O)CC=C |
| TCMBANKIN036174 | 1,3,8-p-Menthatriene | 1,3,8- p- menthatriene; 1-methyl-4-prop-1-en-2-yl-cyclohexa-1,3-diene; 1,3-Cyclohexadiene, 2-methyl-5-(1-methylethenyl)-; 1,3,8-p-menthatriene; 1-isopropenyl-4-methylcyclohexa-1,3-diene; 1-methyl-4-prop-1-en-2-ylcyclohexa-1,3-diene; 1-isopropenyl-4-methyl-cyclohexa-1,3-diene; 18368-95-1 | C10H14 | 134.22 | CC1=CC=C(CC1)C(=C)C |
| TCMBANKIN036187 | Evolitrin | 4-27-00-02210 (Beilstein Handbook Reference); Furo(2,3-b)quinoline, 4,7-dimethoxy-; CCRIS 3579; 523-66-0; 4,7-dimethoxyfuro[2,3-b]quinoline; Evolitrine; BRN 0220214 | C13H11NO3 | 229.23 | COC1=CC2=C(C=C1)C(=C3C=COC3=N2)OC |
| TCMBANKIN036917 | apigenin | 520-36-5; Spectrum2_000428; 10798_FLUKA; Biochem Biophys Res Comm 212: 767 (1997); CCRIS 3789; AIDS001401; apigenin-7-olate; KBioGR_002565; KBio3_002887; BSPBio_000368; 5,7-dihydroxy-2-(4-hydroxyphenyl)chromen-4-one; HSCI1_000221; Flavone, 4',5,7-trihydroxy-; 4H-1-Benzopyran-4-one, 5,7-dihydroxy-2-(4-hydroxyphenyl)-; EINECS 208-292-3; A3145_SIGMA; 7-hydroxy-2-(4-hydroxyphenyl)-4-oxo-1-benzopyran-5-olate; CHEBI:18388; IDI1_000798; NCGC00025057-04; AIDS-001401; NSC 83244; BPBio1_000406; Apigenol; 5,7-dihydroxy-2-(4-hydroxyphenyl)-4-chromenone; NINDS_000798; NCGC00015049-02; 4′,5,7-Trihydroxyflavone; SPBio_002307; Prestwick_719; 2-(4-hydroxyphenyl)-7-oxidanyl-4-oxidanylidene-chromen-5-olate; Spectrum4_001999; Chamomile; KBio1_000798; BRN 0262620; Prestwick2_000414; Prestwick3_000414; SDCCGMLS-0066379.P001; CHEBI:58470; 5,7, 4'-trihydroxyflavone; NCGC00025057-02; 2-(p-Hydroxyphenyl)-5,7-dihydroxychromone; 5,7-dihydroxy-2-(4-hydroxyphenyl)-4H-1-benzopyran-4-one; APIGENIN; Lopac0_000065; K00045; 4′,5,7-Trihydroxyflavone; 5,7-Dihydroxy-2-(4-hydroxyphenyl)-4-benzopyrone; NCGC00025057-09; 5,7-dihydroxy-2-(4-hydroxyphenyl)-4H-chromen-4-one; ACon1_002450; Oprea1_622293; EU-0100065; nchembio790-comp26; 4',5,7-Trihydroxyflavone; NCGC00025057-08; ND-9076; NCGC00025057-01; MEGxp0_000176; Apigenin; 4',5,7-Trihydroxyflavone; apigenin ; Prestwick1_000414; NCGC00015049-01; ZINC00004495; NCGC00025057-05; Spectrum3_001882; BiomolKI_000078; NCI60_041830; Bio1_001354; ghl.PD_Mitscher_leg0.1194; SPECTRUM200846; A828903; DivK1c_000798; 5-18-04-00574 (Beilstein Handbook Reference); 5-hydroxy-2-(4-hydroxyphenyl)-4-oxo-4H-chromen-7-olate; C.I. Natural Yellow 1; 461015-54-3; 4H-1-Benzopyran-4-one, 5,7-dihydroxy-2-(4-hydroxyphenyl)- (9CI); 5,7-dihydroxy-2-(4-hydroxyphenyl)chromone; SMP2_000338; BiomolKI2_000082; Prestwick0_000414; Tocris-1227; Lopac-A-3145; Bio1_000865; NSC83244; Versulin; Pelargidenon 1449; Bio1_000376; Spigenin; 5,7,4'-Trihydroxyflavone; ST056301; UCCF 031; SPBio_000416; Apigenine; C01477; CAS-520-36-5; BSPBio_003384 | C15H10O5 | 270.24 | C1=CC(=CC=C1C2=CC(=O)C3=C(C=C(C=C3O2)O)O)O |
| TCMBANKIN037541 | alpha-Cubebene | α-cubebene; α- cubebene; 17699-14-8; alpha-cubebene; C09647 | C15H24 | 204.351 | C([H])([H])([H])[C@@]1([H])[C@@]2([C@]3([H])C(C([H])([H])[H])=C([H])C2([H])[H])[C@@]3([H])[C@]([H])(C([H])(C([H])([H])[H])C([H])([H])[H])C([H])([H])C1([H])[H] |
| TCMBANKIN038323 | quinic acid | Cyclohexanecarboxylicacid, 1,3,4,5-tetrahydroxy-, (1a,3R,4a,5R); SCHEMBL12464756; Kinate; SCHEMBL13577075; 1,3,4,5-Tetrahydroxycyclohexane-carboxylic acid; quinate; quinicacid; Quinic acid; (3R)-1,3,4,5-tetrakis(oxidanyl)cyclohexane-1-carboxylic acid; Chinate; SCHEMBL14960616; (1R,3R,4S)-1,3,4,5-tetrahydroxycyclohexane-1-carboxylic acid; (3R)-1,3,4,5-tetrahydroxy-1-cyclohexanecarboxylic acid; SCHEMBL39555; A839299 | C7H12O6 | 192.167 | C1([H])(O[H])[C@@]([H])(O[H])C([H])([H])C(C(O[H])=O)(O[H])C([H])([H])[C@]1([H])O[H] |
| TCMBANKIN038566 | Sedoheptulose | Sedoheptulose anhydride monohydrate; MFCD00150523; 2,7-Anhydro-; CTK8G3083; AKOS024319163; SEDOHEPTULOSAN HYDRATE; B7D9656A-970A-4034-801E-AA7465E3007F; SEDOHEPTULOSAN MONOHYDRATE; A-D-altro-heptulopyranose | 210.18 g/mol | ||
| TCMBANKIN039806 | Sarmentosine | 4CN-1777; (Z)-2-methylol-4-[(2R,3R,4S,5S,6R)-3,4,5-trihydroxy-6-methylol-tetrahydropyran-2-yl]oxy-but-2-enenitrile; (Z)-2-(hydroxymethyl)-4-[(2R,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-but-2-enenitrile; (Z)-2-(hydroxymethyl)-4-[(2R,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydropyran-2-yl]oxy-but-2-enenitrile; 2-Butenenitrile, 4-(beta-D-glucopyranosyloxy)-2-(hydroxymethyl)-, (E)-; (Z)-2-(hydroxymethyl)-4-[(2R,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxybut-2-enenitrile; AC1O5Q6P; (Z)-2-(hydroxymethyl)-4-[[(2R,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)-2-tetrahydropyranyl]oxy]but-2-enenitrile; AKOS032948571; Sarmentosine | 275.25 g/mol | ||
| TCMBANKIN040391 | Germacrene D | C16142; (1E,6E,8S)-8-isopropyl-1-methyl-5-methylenecyclodeca-1,6-diene; (1E,6E,8S)-8-isopropyl-1-methyl-5-methylene-cyclodeca-1,6-diene; germacrene-d; (-)-Germacrene D; (1E,6E,8S)-1-methyl-5-methylidene-8-propan-2-yl-cyclodeca-1,6-diene; germacrene d; Germacrene- D; GermacreneD; (1E,6E,8S)-1-methyl-5-methylidene-8-propan-2-ylcyclodeca-1,6-diene; nchembio.2007.29-comp4 | C15H24 | 204.351 | C1([H])([H])C(=C([H])[H])\C([H])=C([H])\[C@]([H])(C([H])(C([H])([H])[H])C([H])([H])[H])C([H])([H])C([H])([H])\C(\C([H])([H])[H])=C([H])\C1([H])[H] |
| TCMBANKIN041677 | febrifugine | CHEMBL3348937; NCGC00273480-01; AJ-27220; (+)-Isofebrifugine; 24159-07-7; MolPort-039-338-781; ZINC1571579; Febrifugine | C16H19N3O3 | 301.34 g/mol | C1CC(C(NC1)CC(=O)CN2C=NC3=CC=CC=C3C2=O)O |
| TCMBANKIN042372 | Preskimmianine | 303.35 | |||
| TCMBANKIN047645 | aconitine | aconitine ; Aconitine | C34H47NO11 | 646 | C1([H])([H])[C@]([H])(OC([H])([H])[H])[C@]2([C@@]([H])([C@@]([H])([C@]3(OC(C([H])([H])[H])=O)[C@@]([H])([C@@]([H])(OC(=O)c4c([H])c([H])c([H])c([H])c4[H])[C@]([C@]([H])(OC([H])([H])[H])[C@]3([H])O[H])( O[H])C5([H])[H])[C@]25[H])[C@]6([H])OC([H])([H])[H])N(C([H])([H])C([H])([H])[H])C7([H])[H])[C@@]6([H])[C@@]7(C([H])([H])OC([H])([H])[H])[C@]1([H])O[H] |
| TCMBANKIN048798 | β-dichroine | beta-dichroine | C16H19N3O3 | 301.34 g/mol | C1CC(C(NC1)CC(=O)CN2C=NC3=CC=CC=C3C2=O)O |
| TCMBANKIN049264 | mesaconitine | C33H45NO11 | 632 | C1([H])([H])[C@]([H])(OC([H])([H])[H])[C@]2([C@@]([H])([C@@]([H])([C@]3(OC(C([H])([H])[H])=O)[C@@]([H])([C@@]([H])(OC(=O)c4c([H])c([H])c([H])c([H])c4[H])[C@]([C@]([H])(OC([H])([H])[H])[C@]3([H])O[H])( O[H])C5([H])[H])[C@]25[H])[C@]6([H])OC([H])([H])[H])N(C([H])([H])[H])C7([H])[H])[C@@]6([H])[C@@]7(C([H])([H])OC([H])([H])[H])[C@]1([H])O[H] | |
| TCMBANKIN057924 | l-aspargine | L-Asn; L-asparatamine; (2S)-2-azaniumyl-3-carbamoylpropanoate; CJ-24207; (2S)-4-amino-2-azaniumyl-4-oxobutanoate; CHEBI:58048; L-beta-asparagine; (2S)-2-azaniumyl-4-azanyl-4-oxidanylidene-butanoate; L-asparagine zwitterion; A820795; (2S)-2-ammonio-3-carbamoylpropanoate; A836895; asparagine; (2S)-4-amino-2-ammonio-4-oxobutanoate;asparagine;L-Asn; L-asparatamine; (2S)-2-azaniumyl-3-carbamoylpropanoate; CJ-24207; (2S)-4-amino-2-azaniumyl-4-oxobutanoate; CHEBI:58048; L-beta-asparagine; (2S)-2-azaniumyl-4-azanyl-4-oxidanylidene-butanoate; L-asparagine zwitterion; A820795; (2S)-2-ammonio-3-carbamoylpropanoate; A836895; (2S)-4-amino-2-ammonio-4-oxobutanoate | C4H8N2O3 | 132.12 g/mol | C(C(C(=O)[O-])[NH3+])C(=O)N |
| TCMBANKIN058221 | apigenin | 520-36-5; Spectrum2_000428; 10798_FLUKA; Biochem Biophys Res Comm 212: 767 (1997); CCRIS 3789; AIDS001401; apigenin-7-olate; KBioGR_002565; KBio3_002887; BSPBio_000368; 5,7-dihydroxy-2-(4-hydroxyphenyl)chromen-4-one; HSCI1_000221; Flavone, 4',5,7-trihydroxy-; 4H-1-Benzopyran-4-one, 5,7-dihydroxy-2-(4-hydroxyphenyl)-; EINECS 208-292-3; A3145_SIGMA; 7-hydroxy-2-(4-hydroxyphenyl)-4-oxo-1-benzopyran-5-olate; CHEBI:18388; IDI1_000798; NCGC00025057-04; AIDS-001401; NSC 83244; BPBio1_000406; Apigenol; 5,7-dihydroxy-2-(4-hydroxyphenyl)-4-chromenone; NINDS_000798; NCGC00015049-02; 4′,5,7-Trihydroxyflavone; SPBio_002307; Prestwick_719; 2-(4-hydroxyphenyl)-7-oxidanyl-4-oxidanylidene-chromen-5-olate; Spectrum4_001999; Chamomile; KBio1_000798; BRN 0262620; Prestwick2_000414; Prestwick3_000414; SDCCGMLS-0066379.P001; CHEBI:58470; 5,7, 4'-trihydroxyflavone; NCGC00025057-02; 2-(p-Hydroxyphenyl)-5,7-dihydroxychromone; 5,7-dihydroxy-2-(4-hydroxyphenyl)-4H-1-benzopyran-4-one; APIGENIN; Lopac0_000065; K00045; 4′,5,7-Trihydroxyflavone; 5,7-Dihydroxy-2-(4-hydroxyphenyl)-4-benzopyrone; NCGC00025057-09; 5,7-dihydroxy-2-(4-hydroxyphenyl)-4H-chromen-4-one; ACon1_002450; Oprea1_622293; EU-0100065; nchembio790-comp26; 4',5,7-Trihydroxyflavone; NCGC00025057-08; ND-9076; NCGC00025057-01; MEGxp0_000176; Apigenin; 4',5,7-Trihydroxyflavone; apigenin ; Prestwick1_000414; NCGC00015049-01; ZINC00004495; NCGC00025057-05; Spectrum3_001882; BiomolKI_000078; NCI60_041830; Bio1_001354; ghl.PD_Mitscher_leg0.1194; SPECTRUM200846; A828903; DivK1c_000798; 5-18-04-00574 (Beilstein Handbook Reference); 5-hydroxy-2-(4-hydroxyphenyl)-4-oxo-4H-chromen-7-olate; C.I. Natural Yellow 1; 461015-54-3; 4H-1-Benzopyran-4-one, 5,7-dihydroxy-2-(4-hydroxyphenyl)- (9CI); 5,7-dihydroxy-2-(4-hydroxyphenyl)chromone; SMP2_000338; BiomolKI2_000082; Prestwick0_000414; Tocris-1227; Lopac-A-3145; Bio1_000865; NSC83244; Versulin; Pelargidenon 1449; Bio1_000376; Spigenin; 5,7,4'-Trihydroxyflavone; ST056301; UCCF 031; SPBio_000416; Apigenine; C01477; CAS-520-36-5; BSPBio_003384 | C15H10O5 | 270.24 | C1=CC(=CC=C1C2=CC(=O)C3=C(C=C(C=C3O2)O)O)O |
| TCMBANKIN058264 | Skimmetin | Hydrangin; AI3-38054; ACon1_000219; Coumarin, 7-hydroxy-; SPBio_002083; H24003_ALDRICH; EINECS 202-240-3; CCRIS 3591; MEGxp0_000814; 7-hydroxy-2H-1-benzopyran-2-one; 7-hydroxy-2-chromenone; BSPBio_002362; NSC19790; 7 HC; Spectrum2_001962; Hydrangine; NSC 19790; ST5308216; 93979_FLUKA; 5-18-01-00386 (Beilstein Handbook Reference); NCGC00095801-01; Skimmetine; BRN 0127683; SPECTRUM231084; beta-umbelliferone; 7-Hydroxycoumarin; Umbelliferon; 7-hydroxy-2H-chromen-2-one; CHEBI:27510; AIDS-005662; Umbelliferone; .beta.-Umbelliferone; Spectrum3_000751; 2H-1-Benzopyran-2-one, 7-hydroxy-; 7-Oxycoumarin; C09315; ZINC00058111; 7-hydroxychromen-2-one; NCI60_001646; 93-35-6; InChI=1/C9H6O3/c10-7-3-1-6-2-4-9(11)12-8(6)5-7/h1-5,10; SDCCGMLS-0066941.P001; AIDS005662; KBio3_001582 | C9H6O3 | 162.14 | C1=CC(=CC2=C1C=CC(=O)O2)O |
| TCMBANKIN058314 | benzaldehyde | SCHEMBL896024; A804633;Benzoic aldehyde;WLN: VHR;InChI=1/C7H6O/c8-6-7-4-2-1-3-5-7/h1-6; CHEBI:17169; Benzene methylal; B1334_ALDRICH; Ald3-H_000012; Benzenecarbonal; Benzaldehyde (natural); NCGC00091819-01; AI3-09931; EINECS 202-860-4; Oil of Bitter Almond; ST5213372; Artificial essential oil of almond; nchembio814-comp15; LS-27; EPA Pesticide Chemical Code 008601; BENZALDEHYDE; W212709_ALDRICH; Ald3.1-H_000160; D02314; Benzenemethylal; NCI-C56133; HSDB 388; 12010_FLUKA; Ald3.1-H_000479; Benzaldehyde FFC; W212717_ALDRICH; Benzene carbaldehyde; CCRIS 2376; 100-52-7; Benzaldehyde [UN1990] [Class 9]; Caswell No. 076; Benzenecarboxaldehyde; Benzoyl hydride; Ald3.1-H_000798; Benzaldehyde (NF); Artificial Almond Oil; Benzaldehyde [USAN]; Artificial Bitter Almond Oil; 09143_FLUKA; C00261; Synthetic oil of bitter almond; FEMA No. 2127; ghl.PD_Mitscher_leg0.170; c0279; 418099_ALDRICH; Benzoic aldehyde; Benzene carboxaldehyde; benzanoaldehyde; Bitter almond oil, synthetic; UN1990; NSC7917; Almond Artificial Essential Oil; NSC 7917; Benzadehyde; Phenylmethanal | C7H6O | 106.12 | C1=CC=C(C=C1)C=O |
| TCMBANKIN058334 | benzene acetaldehyde | benzeneacetaldehyde; HY1; c0210; alpha-Tolyaldehyde; 1-Oxo-2-phenylethane; 107395_ALDRICH; Acetaldehyde,phenyl- (8CI); ZINC00895323; Phenylacetic aldehyde; alpha-Tolualdehyde; NSC406309; alpha-Toluic aldehyde; 2-phenylacetaldehyde; NSC 406309; CHEBI:16424; FEMA No. 2974; 122-78-1; Phenylacetaldehyde solution; .alpha.-Tolualdehyde; W287407_ALDRICH; PHENYLACETALDEHYDE; W287415_ALDRICH; Benzylcarboxaldehyde; .alpha.-Toluic aldehyde; hyacinthin; Acetaldehyde,phenyl-; Phenylethanal; InChI=1/C8H8O/c9-7-6-8-4-2-1-3-5-8/h1-5,7H,6H; NCIOpen2_003602; AI3-02175; 77800_FLUKA; Phenylacetaldehyde (natural); 2-Phenylethanal; Oxophenylethane; Benzeneacetaldehyde; EINECS 204-574-5; C00601; phenylacetaldehyde; Hyacinthin | C8H8O | 120.15 g/mol | C1=CC=C(C=C1)CC=O |
| TCMBANKIN058365 | dicoumarin | SBI-0051343.P003; DSSTox_RID_76296; Kumoran; AS-19619; Z57170530; KBio2_000645; BSPBio_000890; Dicumarolo; 3,3'-Metilen-bis(4-idrossi-cumarina); Prestwick_90; LS-55258; NC 034; 3,3''''''''-methylenebis(4-hydroxy-coumarin; 4-hydroxy-3-[(4-hydroxy-2-oxo-chromen-3-yl)methyl]chromen-2-one; Spectrum3_000387; 3,3'-Methylenebis[4-hydroxy-2H-1-benzopyran-2-one]; 2H-1-Benzopyran-2-one],3'-methylenebis[4-hydroxy-; AC1L19PT; 3,3'-methanediylbis(4-hydroxy-2H-chromen-2-one); C00796; DSSTox_GSID_21729; Bio-0616; CHEMBL43154; Coumarin, 3,3'-methylenebis[4-hydroxy- (8CI); AB00051966_05; Prestwick0_000785; CHEBI:4513; Antitrombosin; STK801287; AC1Q699Q; UNII-7QID3E7BG7; Cumid; HMS502M18; Dwukumarol; D02TJS; 4-hydroxy-3-[(4-hydroxy-2-oxo-2H-chromen-3-yl)methyl]-2H-chromen-2-one; 3,3'-Methylenebis[4-hydroxy-1,2-benzopyrone]; DOBMPNYZJYQDGZ-UHFFFAOYSA-N; Prestwick3_000785; H2893; Spectrum_000165; HMS1570M12; 3,3'-Methylene-bis(4-hydroxycoumarin); bis-hydroxycoumarin; NCGC00016296-04; Dicoumarolum [INN-Latin]; SPBio_000248; MFCD00006857; 5-19-06-00682 (Beilstein Handbook Reference); 3,3'-Methylenebis(4-hydroxy-2H-1-benzopyran-2-one); 3,2-benzopyrone]; Pharmakon1600-01500239; NCGC00094650-02; 3,3'-Methylene-bis(4-hydroxycoumarin), 99%; NSC-17860; Dicumol; CHEMBL1466; CTK5C5178; Temparin; GTPL6808; KBio2_003213; VZ31493; Dicumarol [INN-Spanish]; NSC17860; 3,3'-Methylene-bis(4-hydroxycoumarine) [French]; MolPort-000-422-589; Coumarin, 3,3'-methylenebis[4-hydroxy-(8CI); W-203471; Cuma; IDI1_000896; NCGC00016296-02; 3,3'-Methyleen-bis(4-hydroxy-cumarine); 3,3'-Methyleen-bis(4-hydroxy-cumarine) [Dutch]; HY-N0645; 3,3′-Methylenebis(4-hydroxycoumarin); MCULE-8095183287; SCHEMBL33892; HMS2091M10; 3,3'-methylenebis(4-hydroxy-2H-chromen-2-one); Dicumarol, United States Pharmacopeia (USP) Reference Standard; Dicumarolum; Dicumarolo [DCIT]; 3,3''''''''-methylenebis(4-hydroxycoumarin); NCGC00094650-01; 3,3'-Methylene-bis(4-hydroxycoumarine); SPBio_002829; NSC 41834; Di-4-hydroxy-3,3'-methylenedicoumarin; 2H-1-Benzopyran-2-one,3'-methylenebis[4-hydroxy-; Prestwick1_000785; FT-0624734; NCGC00016296-03; NINDS_000896; DivK1c_000896; Dicumarinum; Di-(4-hydroxy-3-coumarinyl)methane; SR-05000001605; 3,3'-Metilen-bis(4-idrossi-cumarina) [Italian]; CCG-34550; 2H-1-Benzopyran-2-one, 3,3'-methylenebis(4-hydroxy-; NSC 221570; SR-05000001605-1; Dufalone; EINECS 200-632-9; Dicoumarol; NCGC00016296-01; Trombosan; HMS1920E20; Dicoumarol (INN); Tox21_110357; 2H-1-Benzopyran-2-one, 3,3'-methylenebis[4-hydroxy-(9CI); 3,3'-Methylene-bis[4-hydroxycoumarin]; Dicumarol [USAN]; NCGC00016296-07; ChemDiv2_003436; 3,3'-methylenebis(2-hydroxy-4h-chromen-4-one); M0216; Apekumarol; Dicoumal; SPECTRUM1500239; AI3-14546; KBioGR_001055; DB00266; 3,3'-Methylen-bis(4-hydroxy-cumarin); 66-76-2; I14-52299; 4,4'-Dihydroxy-3,3'-methylene bis coumarin; BSPBio_002173; Oprea1_150990; SR-05000001605-3; Dicumarol (TN); BBL008904; BPBio1_000980; HMS3714M12; NSC756733; BG01624449; KBioSS_000645; BRD-K82236179-001-05-0; melitoxin; 3,3 -Methylene-bis[4-hydroxycoumarin]; NCGC00016296-05; Coumarin,3'-methylenebis[4-hydroxy-; Dwukumarol [Polish]; Acavyl; Spectrum4_000508; 3,3-Methylene-bis[4-hydroxycoumarin]; AK325302; Bis(4-hydroxycoumarin-3-yl)methane; D03798; Dicumarol (USAN); dicoumarol; Dikumarol; 2H-1-Benzopyran-2-one, 3,3'-methylenebis(4-hydroxy)-; KBio3_001393; SR-05000001605-4; DSSTox_CID_1729; Baracoumin; 2-hydroxy-3-[(2-hydroxy-4-oxochromen-3-yl)methyl]chromen-4-one; CAS-66-76-2; Dicumarol [USAN:USP]; CBDivE_003005; BDBM35525; Tox21_110357_1; NSC-756733; 3,3'-Methylenebis(4-hydroxy-1,2-benzopyrone); Dicuman; Acadyl; 4-hydroxy-3-((4-hydroxy-2-oxo-2H-chromen-3-yl)methyl)-2H-chromen-2-one; SCHEMBL33891; Dicumaol R; 4-hydroxy-3-[(4-hydroxy-2-oxochromen-3-yl)methyl]chromen-2-one; WLN: T66 BOVJ EQ D1- DT66 BOVJ EQ; NSC 17860; Dicoumarol [INN]; KBio1_000896; Dicoumerol; 3,3'-Methylen-bis(4-hydroxy-cumarin) [German]; NSC221570; Dicumarine; BRN 0335444; Spectrum5_000871; Bis-3,3'-(4-hydroxycoumarinyl)methane; dicumarol; Coumarin, 3,3'-methylenebis(4-hydroxy-; CCRIS 3713; 7QID3E7BG7; KBio2_005781; Y1603; 2H-1-Benzopyran-2-one), 3,3'-methylenebis(4-hydroxy-; CS-7962; Dicoumarolum; HSDB 3223; Prestwick2_000785; 3,3''''''''-methylenebis[4-hydroxycoumarin; DTXSID8021729; s4299; 3,3'-Methylenebis(4-hydroxycoumarin); ZINC3869855; 2H-1-Benzopyran-2-one,3,3'-methylenebis[4-hydroxy-; C19H12O6; 2H-1-Benzopyran-2-one, 3,3'-methylenebis[4-hydroxy- (9CI); 3,3'-Methylenebis[4-hydroxycoumarin]; Anathrombase; NSC41834; 3,3′ HMS3652P10; BG00665451; symmetric dicoumarol analogue, 1; AKOS000520650; Bis-3,3'-(4-oxycoumarinyl)ethylacetate; HMS1378M04; HMS2097M12; 2H-1-Benzopyran-2-one, 3,3'-methylenebis[4-hydroxy-; uncoupler of oxidative respiration; Spectrum2_000144; Bishydroxycoumarin;dicoumarol | C19H12O6 | 336.3 g/mol | C1=CC=C2C(=C1)C(=C(C(=O)O2)CC3=C(C4=CC=CC=C4OC3=O)O)O |
| TCMBANKIN058436 | 2, 4-dihydroxy pyrimidine | NSC3970; C00106; 16908-84-2; U3879_SIGMA; 2,4-Pyrimidinediol; 2-hydroxy-4(3H)-pyrimidinone; 66-22-8; Pirod; 144104-68-7; SQ 7726; Uracil-2-14C; 2,4-Pyrimidinedione; 4433-21-0; D00027; 24897-50-5; U0750_SIGMA; AI3-25470; 766-19-8; U1128_SIGMA; SQ 8493; ST5165192; SQ 6201; 2-hydroxy-4(1H)-pyrimidinone; 2,4-Dioxopyrimidine; 1H-pyrimidine-2,4-dione; Urazil; Pyrod; EINECS 200-621-9; Hybar X; Uracil (JAN/USAN); CHEBI:17568; 6-(3,5-Dimethylbenzyl)-5-ethyl-1-[4-(13-ethyl-17-hydroxy-3-oxo-2,3,6,7,8,9,10,11,12,13,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-ylethynyl)benzyloxymethyl]uracil; Uracil-5-d; NCIMech_000782; AC-907/30002021; 2,4-Dihydroxypyrimidine; 42910-77-0; NSC 3970; NSC29742; ZINC00895045; STK301734; AIDS009895; Uracil (8CI); URACIL; Uracil [USAN]; 6-[(3,5-dimethylphenyl)methyl]-5-ethyl-1-[[4-[2-(13-ethyl-17-hydroxy-3-oxo-1,2,6,7,8,9,10,11,12,14,15,16-dodecahydrocyclopenta[a]phenanthren-17-yl)ethynyl]phenyl]methoxymethyl]pyrimidine-2,4-dione; pyrimidine-2,4(1H,3H)-dione; 4433-24-3; 2,4-(1H,3H)-pyrimidinedione (9CI); CCRIS 3077; RU 12709; Ura; 2,4(1H,3H)-Pyrimidinedione; BMS 205603-01; InChI=1/C4H4N2O2/c7-3-1-2-5-4(8)6-3/h1-2H,(H2,5,6,7,8; 2,4(1H,3H)-Pyrimidinedione (9CI); NCI60_003718; 4-hydroxy-2(1H)-pyrimidinone; 2,4(1H,3H)-Pyrimidinedione, labeled with tritium; AIDS-009895 | C4H4N2O2 | 112.09 g/mol | C1=CNC(=O)NC1=O |
| TCMBANKIN058484 | quinic acid | Cyclohexanecarboxylicacid, 1,3,4,5-tetrahydroxy-, (1a,3R,4a,5R); SCHEMBL12464756; Kinate; SCHEMBL13577075; 1,3,4,5-Tetrahydroxycyclohexane-carboxylic acid; quinate; quinicacid; Quinic acid; (3R)-1,3,4,5-tetrakis(oxidanyl)cyclohexane-1-carboxylic acid; Chinate; SCHEMBL14960616; (1R,3R,4S)-1,3,4,5-tetrahydroxycyclohexane-1-carboxylic acid; (3R)-1,3,4,5-tetrahydroxy-1-cyclohexanecarboxylic acid; SCHEMBL39555; A839299 | C7H12O6 | 192.17 | C1C(C(C(CC1(C(=O)O)O)O)O)O |
| TCMBANKIN058594 | α-Dichroine | alpha - dichroine; α-dichroine; alpha-dichroine;isofebrifugine | C16H19N3O3 | 301.34 g/mol | C1CC2C(CC(O2)(CN3C=NC4=CC=CC=C4C3=O)O)NC1 |
| TCMBANKIN058632 | alpha-berbine | (13aS)-6,8,13,13a-tetrahydro-5H-isoquinolino[2,1-b]isoquinoline; 13aalpha-berbine; (S)-7,8,13,14-Tetrahydroprotoberberine; 131-10-2; C05204; CHEBI:35612; (S)-Tetrahydroprotoberberine; (S)-5,8,13,13a-tetrahydro-6H-dibenzo[a,g]quinolizine; Tetrahydroprotoberberine; 6H-Dibenzo(a,g)quinolizine, 5,8,13,13a-tetrahydro-, (S)-;tetrahydroprotoberberine | C17H17N | 235.32 g/mol | C1CN2CC3=CC=CC=C3CC2C4=CC=CC=C41 |
| TCMBANKIN058638 | higenamine | UNII-6016M93W29; CHEBI:27751; (R)-Norcoclaurine; 6,7-Dihydroxy-(1R)-[(4-hydroxyphenyl)methyl]-1,2,3,4-tetrahydroisoquinoline; 6,7-Isoquinolinediol, 1,2,3,4-tetrahydro-1-((4-hydroxyphenyl)methyl)-, (1R)-; (1R)-1-[(4-hydroxyphenyl)methyl]-1,2,3,4-tetrahydroisoquinoline-6,7-diol; 6016M93W29; SCHEMBL5898913; AX8328517; DTXSID90331552; (+)-HIGENAMINE; UNII-TBV5O16GAP component WZRCQWQRFZITDX-CQSZACIVSA-N; CHEMBL501778; 6,7-Isoquinolinediol, 1,2,3,4-tetrahydro-1-((4-hydroxyphenyl)methyl)-, (R)-; C06347; (R)-(+)-Higenamine; (+)-Demethylcoclaurine; 106032-53-5; BDBM50242856; AC1L9ACA; (1R)-1-(4-hydroxybenzyl)-1,2,3,4-tetrahydroisoquinoline-6,7-diol; AK00743742; (R)-1-(4-Hydroxybenzyl)-1,2,3,4-tetrahydroisoquinoline-6,7-diol; Higenamine, (+)-; ZINC896041; demethylcoclaurine; demetahyl coclaurine | C16H17NO3 | 271.31 g/mol | C1CNC(C2=CC(=C(C=C21)O)O)CC3=CC=C(C=C3)O |
| TCMBANKIN058745 | 3-methyl-2-Butenal;Prenal | CHEBI:15825; .beta.,.beta.-Dimethylacrolein; W364607_ALDRICH; ZINC00896834; 304077_ALDRICH; Crotonaldehyde, 3-methyl- (8CI); 2-BUTENAL, 3-METHYL-; Crotonaldehyde, 3-methyl-; 3-Methylcrotonaldehyde; C15604; Senecioaldehyde; EINECS 203-527-6; InChI=1/C5H8O/c1-5(2)3-4-6/h3-4H,1-2H; 107-86-8; 3,3-Dimethyl-acrylaldehyde; 66260_FLUKA; Senecialdehyde; 3,3-Dimethylacrylaldehyde; beta,beta-Dimethylacrolein; beta-Methylcrotonaldehyde; 3-Methyl-2-butenal; 3,3-Dimethylacrolein; NSC 149164; FEMA No. 3646; .beta.-Methylcrotonaldehyde; NSC149164; beta,beta-Dimethylacrylic aldehyde; 3-Methylbut-2-enal; C07330 | C5H8O | 84.12 g/mol | CC(=CC=O)C |
| TCMBANKIN058957 | n-methylisopelletierine | methyl isopelletierine | C9H17NO | 155.24 g/mol | CC(=O)CC1CCCCN1C |
| TCMBANKIN059061 | l-alpha-alanine | 3ip5; D09ADQ; [14C]-alanine; D0X1RG; CJ-12185; L-alanine zwitterion; CHEBI:57972; 3f48; [14C]alanine; (2S)-2-azaniumylpropanoate; [3H]alanine; (2S)-2-ammoniopropanoate; AC1OIZQD; [3H]-alanine; l-alanine; | C3H7NO2 | 89.09 g/mol | CC(C(=O)[O-])[NH3+] |
| TCMBANKIN059195 | (1S,5S)-1-isopropyl-4-methylenebicyclo[3.1.0]hexane | (1S,5S)-1-isopropyl-4-methylene-bicyclo[3.1.0]hexane; (1S,5S)-4-methylidene-1-propan-2-ylbicyclo[3.1.0]hexane; (1S,5S)-4-methylidene-1-propan-2-yl-bicyclo[3.1.0]hexane | C10H16 | 136.23 g/mol | CC(C)C12CCC(=C)C1C2 |
| TCMBANKIN059238 | l-leucine | (2S)-2-ammonio-4-methylpentanoate; AC1OF6E5; L-Leu; (2S)-2-azaniumyl-4-methylpentanoate; L-leucine zwitterion; 3b3s; 3b3w; (2S)-2-azaniumyl-4-methyl-pentanoate; A833479; CHEBI:57427; 3gjd; 3f3e; 4fxz; leucine zwitterion; CJ-10705; leucine | C6H13NO2 | 131.17 g/mol | CC(C)CC(C(=O)[O-])[NH3+] |
| TCMBANKIN059435 | 2- Butenal | C4H6O | 70.09 g/mol | CC=CC=O | |
| TCMBANKIN059571 | ZINC05224268 | C15H24 | 204.35 | CC1(CC2C1CCC3(C(O3)CCC2=C)C)C | |
| TCMBANKIN059962 | cadinen;α-Cadinene;1,2,4a,5,6,8a-hexahydro-4,7-dimethyl-1-(1-methylethyl)naphthalene;1,2,4A,5,6,8A-hexahydro--4,7-dimethyl-(1-methylethyl)-naphthalene;muurolene;1,2,4a,5,6,8a- hexhydro- 4,7- dimethyl- 1-(1- methylethyl)-(1alpha 4a． alpha．,8a alpha． )- naphthalene;alpha cadinene;α-muurolene | C15H24 | 204.35 g/mol | CC1=CC2C(CC1)C(=CCC2C(C)C)C | |
| TCMBANKIN059964 | α-cadinol | C15H26O | 222.37g/mol | CC1=CC2C(CCC(C2CC1)(C)O)C(C)C | |
| TCMBANKIN060008 | a-bourbonene | C15H24 | 204.35 | CC1=CCC2C1C3C2(CCC3C(C)C)C | |
| TCMBANKIN060009 | copaene; (-)-Alpha-Copaene; α-copaene | C15H24 | 204.35 g/mol | CC1=CCC2C3C1C2(CCC3C(C)C)C | |
| TCMBANKIN060014 | Germacrene D | C15H24 | 204.35 g/mol | CC1=CCCC(=C)C=CC(CC1)C(C)C | |
| TCMBANKIN060569 | patchoulane | C15H26 | 206.37 | CC1CCC23C1CC(C2(C)C)CCC3C | |
| TCMBANKIN060593 | ()-Aromadendrene;(+)-aromadendrene | C15H24 | 204.35 | CC1CCC2C1C3C(C3(C)C)CCC2=C | |
| TCMBANKIN060679 | stigmasterol | C29H48O | 412.7 g/mol | CCC(C=CC(C)C1CCC2C1(CCC3C2CC=C4C3(CCC(C4)O)C)C)C(C)C | |
| TCMBANKIN060693 | Sitogluside | C35H60O6 | 576.85g/mol | CCC(CCC(C)C1CCC2C1(CCC3C2CC=C4C3(CCC(C4)OC5C(C(C(C(O5)CO)O)O)O)C)C)C(C)C | |
| TCMBANKIN060737 | 2-ethylfuran | C6H8O | 96.13 g/mol | CCC1=CC=CO1 | |
| TCMBANKIN060790 | leaf aldehyde | C6H10O | 98.14 g/mol | CCCC=CC=O | |
| TCMBANKIN060888 | caproaldehyde | C6H12O | 100.16 g/mol | CCCCCC=O | |
| TCMBANKIN060994 | capraldehyde | C10H20O | 156.26 g/mol | CCCCCCCCCC=O | |
| TCMBANKIN061296 | Japonine | C18H17NO3 | 295.33 | CN1C2=C(C=C(C=C2)OC)C(=O)C(=C1C3=CC=CC=C3)OC | |
| TCMBANKIN061466 | Isovanillic acid | BRN 2208365; Benzoic acid, 3-hydroxy-4-methoxy-; ST5406548; InChI=1/C8H8O4/c1-12-7-3-2-5(8(10)11)4-6(7)9/h2-4,9H,1H3,(H,10,11; 3-Hydroxyanisic acid; 220108_ALDRICH; Acide isovanillique; 3-HYDROXY-4-METHOXYBENZOIC ACID; isovanillic acid; EINECS 211-430-5; p-Anisic acid, 3-hydroxy-; 3-Hydroxy-p-anisic acid; 3-hydroxy-4-methoxy-benzoic acid;3-hydroxy-4-methoxy benzoicacid;3-Hydroxy-4-methoxybenzoic acid; 3- hydroxy- 4- methoxy- benzoic acid | C8H8O4 | 168.15 g/mol | COC1=C(C=C(C=C1)C(=O)O)O |
| TCMBANKIN061473 | Isovanillin | 3-Hydroxy-4-anisaldehyde; 3-Hydroxy-4-methoxybenzaldehyde; FT-0615821; ANW-34085; 4-Methoxy-3-hydroxy-benzaldehyde; DSSTox_RID_83498; ACMC-209n07; 4-methoxy-5-hydroxybenzaldehyde; NCGC00247609-01; BR-26987; SMR000156287; 143685_ALDRICH; BG01499429; CHEMBL275563; AK-26987; SBB008245; SC-05820; Q-100718; 3-Hydroxy-4-methoxybenzaldehyde; 3-hydroxy-4-anisaldehyde; MCULE-7646011311; 621-59-0; PubChem7770; F1995-0251; RTC-060637; 3-hydroxy-4-methoxy- benzaldehyde; 3-hydroxy-4-methoxy- benzaldehyde;BB_NC-2245; 3-Hydroxyanisaldehyde; AJ-16240; DSSTox_GSID_49423; 4A9N90H9X6; PS-4589; Isovanilline; 3-Hydroxy-para-anisaldehyde; MolPort-000-146-016; 3-hydroxy-4methoxy-benzaldehyde; NSC82996; SCHEMBL70256; BC204204; JVTZFYYHCGSXJV-UHFFFAOYSA-N; Tox21_202858; 4-Methoxy-3-hydroxybenzaldehyde; KS-000002MN; DTXSID7049423; 3-hydroxy-4-methoxy benzaldehyde; p-Anisaldehyde, 3-hydroxy- (8CI); Benzaldehyde, 3-hydroxy-4-methoxy-; AN-15747; D0E9CD; EBD684885; isovanillin; I0519; LS10550; A833619; 59927_FLUKA; HMS3348H19; Isovanicaline; 4-methoxy-3-oxidanyl-benzaldehyde; 3-Hydroxy-4-methoxy-benzaldehyde; LS-25072; 4-08-00-01764 (Beilstein Handbook Reference); HMS2194I16; AC-541; KSC354M3B; ZINC164617; Isovanillin, >=95.0%; ISOVANILLIN; ST50213460; I01-0153; BBL023550; NCGC00260404-01; BG00600677; NSC 82996; WLN: VHR CQ DO1; isovanilin; BRN 1073021; NSC-82996; 3-hydroxy-4-methoxy-benzaldehyde; CJ-02189; ZB008229; MLS000574853; Oxy-3 methoxy-4 benzaldehyde; DSSTox_CID_29383; CS-W009023; NCIOpen2_001085; 3-Hydroxy-4-methoxybenzaldehyde, 99%; DB-010058; 3-Hydroxyanisaldehyde; Isovanillin; 59940_FLUKA; ST24022906; AC1Q469E; STK400134; TRA0093875; InChI=1/C8H8O3/c1-11-8-3-2-6(5-9)4-7(8)10/h2-5,10H,1H; AKOS000120260; 3-hydroxy4-methoxybenzaldehyde; M-6105; CAS-621-59-0; TC-060637; TL8004050; AB1002458; CM13992; Oxy-3 methoxy-4 benzaldehyde [French]; p-Anisaldehyde, 3-hydroxy-; CTK2F4630; iso-Vanillin; AC1L1YWO; 5-Formylguaiacol; FT-0615853; 21I590; isovaniline; ZINC00164617; RP21587; KB-32136; BDBM50240367; 3-Hydroxy-p-anisaldehyde; P-Anisaldehyde, 3-hydroxy-(8CI); UNII-4A9N90H9X6; EINECS 210-694-9; MFCD00003369 | C8H8O3 | 152.15 | COC1=C(C=C(C=C1)C=O)O |
| TCMBANKIN061698 | Dictamine | Spectrum3_000101; SPECTRUM100541; C10660; Furo(2,3-b)quinoline, 4-methoxy-; dictamnine; Furo[2,3-b]quinoline, 4-methoxy-; KBio2_006213; NCGC00095429-01; SDCCGMLS-0066336.P001; Dictamnine; CCRIS 1583; Spectrum2_000349; Oprea1_294767; KBio3_000802; 484-29-7; Spectrum4_001383; dictamine ; Oprea1_134081; DivK1c_006140; SPBio_000417; SpecPlus_000044; 4-methoxyfuro[2,3-b]quinoline; Spectrum_000597; KBio2_003645; KBioSS_001077; BSPBio_001682; KBio2_001077; dictamine; KBioGR_001706; KBio1_001084; Spectrum5_000086; 4-27-00-02030 (Beilstein Handbook Reference); BRN 0176932;Spectrum3_000101; SPECTRUM100541; AC1L2901; LS-70926; C10660; Furo(2,3-b)quinoline, 4-methoxy-; DTXSID0041012; Furo[2,3-b]quinoline, 4-methoxy-; MCULE-6817939774; MolPort-003-665-620; C12H9NO2; AM-331/20711025; KBio2_006213; CTK4J0807; NCGC00095429-01; AKOS006274709; SDCCGMLS-0066336.P001; Dictamnine; Furo[2,3-b]quinoline,4-methoxy-; NCGC00095429-02; CCRIS 1583; FT-0686595; Spectrum2_000349; Oprea1_294767; V0176; KBio3_000802; 4-Methoxyfuro[2,3-b]quinoline #; 484-29-7; Spectrum4_001383; BRD-K29178788-001-01-2; 4-Methoxyfuro[2,3-b]quinoline; CCG-38624; Oprea1_134081; DivK1c_006140; SR-05000002442; Q-100537; WIONIXOBNMDJFJ-UHFFFAOYSA-N; SPBio_000417; SR-05000002442-1; SpecPlus_000044; CS-3267; Spectrum_000597; N2224; 484D297; CHEBI:4512; KBio2_003645; BSPBio_001682; KBioSS_001077; HQZ3798D0A; Diktaminin; SCHEMBL1760700; Dictamine; CHEMBL22533; VU0243862-3; HY-N0849; KBio2_001077; KBioGR_001706; UNII-HQZ3798D0A; HMS3561L11; AN-45222; 4-Methoxy-furo[2,3-b]quinoline; ZINC265517; AC1Q4FDA; KBio1_001084; Spectrum5_000086; 4-27-00-02030 (Beilstein Handbook Reference); BRN 0176932 | C12H9NO2 | 199.21 | COC1=C2C=COC2=NC3=CC=CC=C31 |
植物对应的疾病
| 疾病ID | 病名 | 疾病类型 | MeSH | 参考文献 |
|---|
植物对应的靶点
| 靶点ID | 基因名 | 基因别名 | 描述 | 染色体位置 | Map_Location | 基因类型 |
|---|
滇ICP备16009434号-1 |
Dai SX Lab